Table 2.
Demographics by treatment groups
| Study | Sample size, n | Sample size, n | Mean (SD) age, y | Male, n (%) | Ethnic origina, n (%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ceftaroline group | Control group | Ceftaroline group | Control group | Ceftaroline group | Control group | Ceftaroline group | Control group | ||
| Jandourek et al...., 2014 [9] | 45 | 23 | 22 | 60.6 (16.1) | 63.2 (16.2) | 15 (65.2) | 17 (77.3) | – | – |
| File et al.., 2011 [10] | 591 | 291 | 300 | 61.0 (16.6) | 61.2 (16.4) | 187 (64.3) | 191 (63.7) | 260 (89.3) | 268 (83.3) |
| Low et al, 2011 [11] | 562 | 289 | 273 | 60.6 (16.1) | 62.0 (14.7) | 175 (60.6) | 175 (64.1) | 278 (96.2) | 264 (96.7) |
| Shorr et al..., 2013 [12] | 139 | 69 | 70 | 63 (17) | 62 (15) | 43 (62.3) | 47 (67.1) | – | – |
| File et al., 2010 [13] | 1153 | 580 | 573 | 60.8 (16.4) | 61.6 (15.6) | 362 (62.4) | 366 (63.9) | 538 (92.8) | 532 (92.8) |
| Zhong et al, 2015 [14] | 763 | 381 | 382 | 66.1 (14.7) | 65.8 (13.9) | 265 (69.6) | 272 (71.2) | 381 (100.0) A | 382 (100.0) A |
| Arshad et al...., 2016 [15] | 149 | 40 | 109 | 58.8 (16.1) | 58.8 (16.4) | 20 (50.0) | 54 (49.5) | 16 (40.0) B | 46 (42.2) B |
| Eckburg et al.., 2012 [22] | 309 | 154 | 155 | 59.9 (17.7) | 60.5 (16.0) | 99 (64.3) | 97 (62.6) | – | – |
aProportion of white patients, unless otherwise specified as black (B), or Asian (A)